Beyond Human-in-the-Loop: Why AI in Pharma Needs Human-Aided Intelligence (HAI)

AI is transforming how pharmaceutical organizations create, review, and manage information. But in a highly regulated industry where scientific integrity, patient safety, and compliance matter, keeping a human in the loop is only the beginning. Human-Aided Intelligence (HAI) takes the next step by equipping experts with the right context, insights, and information to make better-informed decisions.

Whitepaper Scope

This whitepaper explores how Life Sciences organizations can move beyond human oversight to continuous human-AI collaboration. Using Medical, Legal, and Regulatory (MLR) review as a case in point, it outlines how AI can prepare, organize, and surface relevant information while keeping human judgment and accountability at the center.

What’s Inside

• Beyond Human-in-the-Loop: Understand how HAI shifts AI from a tool that requires review to an intelligence layer that continuously supports human decision-making.

• HAI in MLR Review: Explore how AI can organize claims, validate references, surface regulatory guidance, and flag potential risks before expert review.

• Protecting Expert Attention: Discover how AI can reduce routine information-gathering effort and help experts focus on complex, high-value decisions.

• Designing Human-AI Workflows: Learn five principles for embedding AI into existing processes with clear roles, responsibilities, and human oversight.

• Real-World Applications: Explore how HAI can support MLR review, clinical development, commercial and market access, and research and scientific strategy.

Who Should Read This?

• Pharma Medical, Legal, and Regulatory (MLR) leaders

• Medical Affairs and Commercial Operations teams

• Clinical Development and Regulatory Affairs leaders

• Market Access and Pharmaceutical Marketing teams

• Digital Transformation, AI, and Innovation leaders in Life Sciences

What You’ll Take Away

• A practical understanding of how HAI differs from traditional human-in-the-loop AI.

• A framework for combining AI capabilities with human expertise and accountability.

• Insights into preparing reviewers with relevant context, risks, and evidence before decisions.

• Five principles for designing effective human-AI workflows.

• Use cases for applying HAI across the Life Sciences value chain.

This whitepaper offers a practical perspective on making AI work with people, not simply around them. Discover how Human-Aided Intelligence can help Pharma organizations make better-informed decisions, preserve expert attention, and translate AI capabilities into meaningful business impact.

Read the whitepaper to explore the future of human-AI collaboration in Life Sciences.